Effect of Continuous Positive Airway Pressure on Cardiovascular Biomarkers: The Sleep Apnea Stress Randomized Controlled Trial

Chest

Volumn 150, Issue 1, 2016, Pages 80-90

  Paz y Mar, Hugo L ^a   Hazen, Stanley L ^a   Tracy, Russell P ^b   Strohl, Kingman P ^c   Auckley, Dennis ^d   Bena, James ^a   Wang, Lu ^a   Walia, Harneet K ^a   Patel, Sanjay R ^e   Mehra, Reena ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d METROHEALTH MEDICAL CENTER   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CPAP; inflammation; obstructive sleep apnea

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; ISOPROSTANE DERIVATIVE; LIPOPROTEIN A; MYELOPEROXIDASE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXYGEN; BIOLOGICAL MARKER; PEROXIDASE;

ADULT; AGED; APNEA HYPOPNEA INDEX; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; CARDIOVASCULAR RISK; CONTROLLED STUDY; CPAP DEVICE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPOXIA; INFLAMMATION; INTENTION TO TREAT ANALYSIS; LEAST SQUARE ANALYSIS; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PARALLEL DESIGN; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; SLEEP DISORDERED BREATHING; STATISTICAL MODEL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; BLOOD; CARDIOVASCULAR DISEASES; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; SLEEP APNEA, OBSTRUCTIVE; STATISTICS;

ADULT; BIOMARKERS; CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; F2-ISOPROSTANES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PEROXIDASE; RECEPTORS, INTERLEUKIN-6; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; STATISTICS AS TOPIC;

EID: 84990052987     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.03.002     Document Type: Article

References (55)

1. 1 Peppard, P.E., Young, T., Barnet, J.H., Palta, M., Hagen, E.W., Hla, K.M., Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177:9 (2013), 1006–1014.
2. 2 Marin, J.M., Carrizo, S.J., Vicente, E., Agusti, A.G.N., Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:9464 (2005), 1046–1053.
3. 3 Nieto, F.J., Young, T.B., Lind, B.K., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283:14 (2000), 1829–1836.
4. 4 Young, T., Peppard, P., Palta, M., et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157:15 (1997), 1746–1752.
5. 5 Punjabi, N.M., Caffo, B.S., Goodwin, J.L., et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med, 6(8), 2009, e1000132.
6. 6 Elmasry, A., Lindberg, E., Hedner, J., Janson, C., Boman, G., Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study. Eur Respir J 19:3 (2002), 511–517.
7. 7 Lavie, L., Obstructive sleep apnoea syndrome – an oxidative stress disorder. Sleep Med Rev 7:1 (2003), 35–51.
8. 8 Weiss, J.W., Remsburg, S., Garpestad, E., Ringler, J., Sparrow, D., Parker, J.A., Hemodynamic consequences of obstructive sleep apnea. Sleep 19:5 (1996), 388–397.
9. 9 Iturriaga, R., Andrade, D.C., Rio, R Del, Enhanced carotid body chemosensory activity and the cardiovascular alterations induced by intermittent hypoxia. Front Physiol, 5, 2014, 468.
10. 10 Chen, L., Einbinder, E., Zhang, Q., Hasday, J., Balke, C.W., Scharf, S.M., Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med 172:7 (2005), 915–920.
11. 11 Troncoso Brindeiro, C.M., Silva, AQ da, Allahdadi, K.J., Youngblood, V., Kanagy, N.L., Reactive oxygen species contribute to sleep apnea-induced hypertension in rats. Am J Physiol Heart Circ Physiol 293:5 (2007), H2971–H2976.
12. 12 Zhou, W., Li, S., Wan, N., Zhang, Z., Guo, R., Chen, B., Effects of various degrees of oxidative stress induced by intermittent hypoxia in rat myocardial tissues. Respirol Carlton Vic 17:5 (2012), 821–829.
13. 13 Jun, J., Savransky, V., Nanayakkara, A., et al. Intermittent hypoxia has organ-specific effects on oxidative stress. Am J Physiol Regul Integr Comp Physiol 295:4 (2008), R1274–R1281.
14. 14 Lin, Q.-C., Chen, L.-D., Chen, G.-P., et al. Association between nocturnal hypoxia and liver injury in the setting of nonalcoholic fatty liver disease. Sleep Breath Schlaf Atm 19:1 (2015), 273–280.
15. 15 Peng, Y.-J., Nanduri, J., Yuan, G., et al. NADPH oxidase is required for the sensory plasticity of the carotid body by chronic intermittent hypoxia. J Neurosci Off J Soc Neurosci 29:15 (2009), 4903–4910.
16. 16 Ben, M Del, Fabiani, M., Loffredo, L., et al. Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment. BMC Pulm Med, 12, 2012, 36.
17. 17 Dyugovskaya, L., Lavie, P., Lavie, L., Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:7 (2002), 934–939.
18. 18 Oyama, J., Yamamoto, H., Maeda, T., Ito, A., Node, K., Makino, N., Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clin Cardiol 35:4 (2012), 231–236.
19. 19 Schulz, R., Mahmoudi, S., Hattar, K., et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:2 Pt 1 (2000), 566–570.
20. 20 Svatikova, A., Wolk, R., Lerman, L.O., et al. Oxidative stress in obstructive sleep apnoea. Eur Heart J 26:22 (2005), 2435–2439.
21. 21 Alonso-Fernández, A., García-Río, F., Arias, M.A., et al. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 64:7 (2009), 581–586.
22. 22 Vlachantoni, I.-T., Dikaiakou, E., Antonopoulos, C.N., Stefanadis, C., Daskalopoulou, S.S., Petridou, E.T., Effects of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea in arterial stiffness: a meta-analysis. Sleep Med Rev 17:1 (2013), 19–28.
23. 23 Lima, AMJ de, Franco, C.M.R., Castro, CMMB de, Bezerra, A. de A., Ataíde, L., Halpern, A., Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respir Int Rev Thorac Dis 79:5 (2010), 370–376.
24. 24 Kartali, N., Daskalopoulou, E., Geleris, P., et al. The effect of continuous positive airway pressure therapy on blood pressure and arterial stiffness in hypertensive patients with obstructive sleep apnea. Sleep Breath Schlaf Atm 18:3 (2014), 635–640.
25. 25 Christou, K., Kostikas, K., Pastaka, C., Tanou, K., Antoniadou, I., Gourgoulianis, K.I., Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med 10:1 (2009), 87–94.
26. 26 Bakker, J.P., Campbell, A.J., Neill, A.M., Pulse wave analysis in a pilot randomised controlled trial of auto-adjusting and continuous positive airway pressure for obstructive sleep apnoea. Sleep Breath Schlaf Atm 15:3 (2011), 325–332.
27. 27 Drager, L.F., Bortolotto, L.A., Figueiredo, A.C., Krieger, E.M., Lorenzi, G.F., Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176:7 (2007), 706–712.
28. 28 Ashraf, F., Tracy, R., Li, H., Auckley, D., Patel, S., Walia, H., Mehra, R., Effects of obstructive sleep apnea treatment on systemic inflammation: results of the sleep apnea stress study (SASS) randomized controlled trial (oral presentation). Annual Meeting of Associated Professional Sleep Societies, 2014.
29. 29 Paz y, Mar H., Li, H., Auckley, D., Patel, S., Walia, H., Strohl, K., Mehra, R., Effects of continuous positive airway pressure on measures of arterial stiffness in obstructive sleep apnea: Results of the sleep apnea stress study randomized controlled trial (oral presentation). Annual Meeting of Associated Professional Sleep Societies, 2014.
30. 30 Brennan, M.-L., Penn, M.S., Van, Lente F., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349:17 (2003), 1595–1604.
31. 31 Oxidative Stress/Inflammation and Heart, Lung, Blood, and Sleep Disorders. 2011. National Heart, Lung, and Blood Institute website. http://www.nhlbi.nih.gov/research/reports/2004-oxidative-stress. Accessed April 12, 2016.
32. 32 Chirinos, J.A., Kips, J.G., Jacobs, D.R., et al. Arterial wave reflections and incident cardiovascular events and heart failure: MESA (Multiethnic Study of Atherosclerosis). J Am Coll Cardiol 60:21 (2012), 2170–2177.
33. 33 Chirinos, J.A., Zambrano, J.P., Chakko, S., et al. Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 45:5 (2005), 980–985.
34. 34 Sivam, S., Witting, P.K., Hoyos, C.M., et al. Effects of 8 weeks of CPAP on lipid-based oxidative markers in obstructive sleep apnea: a randomized trial. J Sleep Res 24:3 (2015), 339–345.
35. 35 Stradling, J.R., Schwarz, E.I., Schlatzer, C., et al. Biomarkers of oxidative stress following continuous positive airway pressure withdrawal: data from two randomised trials. Eur Respir J 46:4 (2015), 1065–1071.
36. 36 Hoffmann, M.S., Singh, P., Wolk, R., Narkiewicz, K., Somers, V.K., Obstructive sleep apnea and intermittent hypoxia increase expression of dual specificity phosphatase 1. Atherosclerosis 231:2 (2013), 378–383.
37. 37 Gillebert, T.C., Lew, W.Y., Influence of systolic pressure profile on rate of left ventricular pressure fall. Am J Physiol 261:3 Pt 2 (1991), H805–H813.
38. 38 Kobayashi, S., Yano, M., Kohno, M., et al. Influence of aortic impedance on the development of pressure-overload left ventricular hypertrophy in rats. Circulation 94:12 (1996), 3362–3368.
39. 39 Phillips, C., Hedner, J., Berend, N., Grunstein, R., Diurnal and obstructive sleep apnea influences on arterial stiffness and central blood pressure in men. Sleep 28:5 (2005), 604–609.
40. 40 Hoyos, C.M., Yee, B.J., Wong, K.K., Grunstein, R.R., Phillips, C.L., Treatment of Sleep Apnea With CPAP Lowers Central and Peripheral Blood Pressure Independent of the Time-of-Day: a randomized controlled study. Am J Hypertens 28:10 (2015), 1222–1228.
41. 41 Morris, A.A., Patel, R.S., Binongo, J.N.G., et al. Racial differences in arterial stiffness and microcirculatory function between Black and White Americans. J Am Heart Assoc, 2(2), 2013, e002154.
42. 42 Park, J.B., Ha, J.-W., Jung, H.-O., Rhee, M.-Y., FOCUS Investigators. Randomized trial comparing the effects of a low-dose combination of nifedipine GITS and valsartan versus high-dose monotherapy on central hemodynamics in patients with inadequately controlled hypertension: FOCUS study. Blood Press Monit 19:5 (2014), 294–301.
43. 43 Kohler, M., Pepperell, J.C.T., Casadei, B., et al. CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 32:6 (2008), 1488–1496.
44. 44 Litvin, A.Y., Sukmarova, Z.N., Elfimova, E.M., et al. Effects of CPAP on “vascular” risk factors in patients with obstructive sleep apnea and arterial hypertension. Vasc Health Risk Manag 9 (2013), 229–235.
45. 45 Jones, A., Vennelle, M., Connell, M., et al. The effect of continuous positive airway pressure therapy on arterial stiffness and endothelial function in obstructive sleep apnea: a randomized controlled trial in patients without cardiovascular disease. Sleep Med 14:12 (2013), 1260–1265.
46. 46 Kohler, M., Craig, S., Pepperell, J.C.T., et al. CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trial. Chest 144:3 (2013), 896–902.
47. 47 Sarwar, N., Butterworth, A.S., et al. IL6R Genetics Consortium Emerging Risk Factors Collaboration. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 379:9822 (2012), 1205–1213.
48. 48 Meléndez, G.C., McLarty, J.L., Levick, S.P., Du, Y., Janicki, J.S., Brower, G.L., Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 56:2 (2010), 225–231.
49. 49 Kobara, M., Noda, K., Kitamura, M., et al. Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice. Cardiovasc Res 87:3 (2010), 424–430.
50. 50 Nian, M., Lee, P., Khaper, N., Liu, P., Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94:12 (2004), 1543–1553.
51. 51 Mehra, R., Storfer-Isser, A., Kirchner, H.L., et al. Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder. Arch Intern Med 166:16 (2006), 1725–1731.
52. 52 Arnardottir, E.S., Lim, D.C., Keenan, B.T., et al. Effects of obesity on the association between long-term sleep apnea treatment and changes in interleukin-6 levels: the Icelandic Sleep Apnea Cohort. J Sleep Res 24:2 (2015), 148–159.
53. 53 Kritikou, I., Basta, M., Vgontzas, A.N., et al. Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females. Eur Respir J 43:1 (2014), 145–155.
54. 54 Arias, M.A., García-Río, F., Alonso-Fernández, A., et al. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J 32:4 (2008), 1009–1015.
55. 55 Stradling, J.R., Craig, S.E., Kohler, M., et al. Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA. Thorax 70:2 (2015), 181–182.